Related Experiment Video
Updated: Nov 23, 2025

07:03
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
6.9K
Regulation of osteoclast function via Rho-Pkn3-c-Src pathways.
Shunsuke Uehara1, Nobuyuki Udagawa2, Yasuhiro Kobayashi3
1Department of Biochemistry, Matsumoto Dental University, Nagano, 399-0781, Japan.
Journal of Oral Biosciences
|August 11, 2019
Summary
Wnt5a-Ror2 signaling enhances osteoclast bone resorption via the Daam2-Rho-Pkn3-c-Src pathway. Pkn3 inhibition may treat osteoporosis and inflammatory bone diseases.
Area of Science:
- Cell Biology
- Molecular Biology
- Bone Biology
Background:
- Wnt signaling pathways are crucial in bone metabolism, with canonical and non-canonical pathways having distinct roles.
- Previous research indicated Wnt5a-receptor tyrosine kinase-like orphan receptor 2 (Ror2) signaling promotes osteoclast differentiation.
- The precise function of Wnt5a-Ror2 signaling in mature osteoclast activity remained undetermined.
Purpose of the Study:
- To elucidate the role of Wnt5a-Ror2 signaling in osteoclast function and bone resorption.
- To identify downstream effectors and molecular mechanisms involved in Wnt5a-Ror2-mediated osteoclast activity.
Main Methods:
- Utilized osteoclast-specific Ror2-deficient mice (Ror2ΔOCL/ΔOCL) and protein kinase N3 (Pkn3)-deficient mice.
- Investigated the activation of Rho and its downstream effectors, including Pkn3, in osteoclasts.
- Analyzed the interaction of Pkn3 with c-Src and Pyk2 and its impact on kinase activity.
Main Results:
- Osteoclast-specific Ror2 deficiency led to increased trabecular bone mass due to reduced osteoclast bone-resorbing activity.
- Wnt5a-Ror2 signaling activated Rho via dishevelled-associated activator of morphogenesis 2 (Daam2) in osteoclasts.
- Pkn3 expression increased during osteoclast differentiation, and Pkn3 deficiency also resulted in greater trabecular bone mass.
- Pkn3 directly bound to c-Src and Pyk2, enhancing c-Src kinase activity in a Wnt5a-Ror2-dependent manner, which is essential for osteoclast bone resorption.
Conclusions:
- Wnt5a-Ror2 signaling stimulates osteoclast bone-resorbing activity through the Daam2-Rho-Pkn3-c-Src pathway.
- Pkn3 is a key mediator in Wnt5a-Ror2 signaling's effect on osteoclast function.
- Targeting Pkn3 presents a potential therapeutic strategy for osteoporosis and inflammatory bone diseases.

